Navigation Links
ACORN's Oncology-focused Contract Research Organization Exceeds Projections
Date:3/31/2008

Accelerated Community Oncology Research Network, Inc. Surpasses 2007

Outlook

MEMPHIS, Tenn., March 31 /PRNewswire/ -- The Accelerated Community Oncology Research Network, Inc. (ACORN), a national oncology clinical trial network, announced today that its Contract Research Organization (CRO) exceeded performance expectations over the past 12 months. ACORN's CRO provides the full range of research services to sponsors, from clinical trial design to site selection to the results phase with bioanalysis and findings presentation. "Sponsors have embraced the strength of ACORN CRO oncology focus. We are pleased that our activity in 2007 exceeded our projections and 1st Q 2008 appears equally impressive," remarked Steve Coplon, CEO.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071112/CLM151LOGO )

Exclusively focused on oncology, ACORN CRO is backed by scientists and medical professionals dedicated to advancing cancer care through research. An important added strength resides in ACORN's network of community oncology researchers, specifically selected because of their commitment to oncology research and excellence in its execution. Close working relationships with demographically diverse US oncology practices result.

ACORN, Inc., a privately held company, significantly enhances the speed, accuracy, and productivity of conducting clinical research in the community oncology setting. Proactive project management with focused teams of clinical experts achieves these goals. Well-defined processes augmented by proprietary technology provide oversight and efficiencies on study functions for both pharma and participating sites.

Strong site relationships enable ACORN CRO to achieve enrollment targets within required timelines. Well-defined processes for site selection include comprehensive study-specific questionnaires, feasibility assessments, and expert evaluation of potential sites, ensuring a high probability of success for each study.

ACORN CRO project teams collaborate with sponsors and stay in close contact with investigator sites. Detailed communication, from kick-off meetings to weekly teleconferences to tracking each study ensures that sponsors are current with their study progress. Advanced technology enables comprehensive metrics reports for in-depth study status.

For additional information visit http://www.ACORNresearch.net or contact Liz Conway, Director of Marketing and Corporate Services, 901-259-0878.

Accelerated Community Oncology Research Network, Inc. (ACORN) ACORN focuses on oncology exclusively. ACORN offers centralized clinical trial services, scientific analysis, and is a full-service Clinical Research Organization (CRO), providing contract and budgeting services; fostering accrual of subjects at the site level; collecting data and monitoring its accuracy; and working seamlessly with both trial sponsors and participating practices.

Contact Information:

Liz Conway

(901) 435-5570

lconway@sosacorn.com

http://www.ACORNresearch.net

Deborah D. Coble

901-683-0055x1312

dcoble@sosacorn.com


'/>"/>
SOURCE Accelerated Community Oncology Research Network, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
2. AcroMetrix Renews Contract With Group Services for Americas Blood Centers
3. U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSCs DVC and Baxter
4. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
5. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
6. Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Companys Anthrax Therapeutic
7. Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
8. Medicare Contractor Establishes Reimbursement Coding Guidance for Monograms Trofile Assay
9. Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics BioZ(R) ICG Technology
10. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
11. Low Acid Coffee Backed By Scientific Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 8, 2016  Diplomat Pharmacy, Inc. (NYSE: DPLO) has been recognized ... Top Workplaces National Standard. To learn more about ... ... Inc.) ... survey administered by WorkplaceDynamics, LLC, a research firm specializing in organizational ...
(Date:12/8/2016)... Research and Markets has announced the addition ... Adhesion Type, Application, Usability - Forecast to 2025" report to ... , , ... poised to grow at a CAGR of around 3.2% from 2015 ... witnessing include advancements in extracellular microelectrode arrays and intracellular microelectrodes, research ...
(Date:12/8/2016)... Dec. 8, 2016  Pennsylvania Physician General Dr. ... and Alcohol Programs Gary Tennis released ... known as benzodiazepines, developed with the help of ... medications that are frequently prescribed for anxiety or ... used with opioid pain medications, benzodiazepines pose a ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... 2016 , ... After enjoying record-breaking attendance at its last ... 33rd Annual Issues & Research Conference, March 2-3, 2017, at the Westin ... is “Persistent Challenges and New Opportunities: Using Research to Accelerate the Dialogue." 2016 ...
(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused on ... efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, Jr. ... honored to team up with Upstage Lung Cancer in order to make major strides ...
(Date:12/8/2016)... (PRWEB) , ... December 08, ... ... Presence Suite 10.2 version gives development continuity to its innovative Unified Instance ... channels management capacity. In addition, this new version optimizes the unattended auto-dialing ...
(Date:12/8/2016)... Peachtree City, Ga (PRWEB) , ... December 08, ... ... and moving as soon after surgery as possible. With this in mind, SIGVARIS ... vein thrombosis (DVT or blood clot) during bed rest and provide the benefits ...
(Date:12/8/2016)... ... December 08, 2016 , ... The ... offices headquartered in Jefferson County, is announcing the launch of a charity drive ... The number of homeless women and children in Birmingham has grown steadily since ...
Breaking Medicine News(10 mins):